Development of new plasmid DNA vaccine vectors with R1-based replicons
Background: There has been renewed interest in biopharmaceuticals based on plasmid DNA (pDNA) in recent years due to the approval of several veterinary DNA vaccines, on-going clinical trials of human pDNA-based therapies, and significant advances in adjuvants and delivery vehicles that have helped o...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
BioMed Central Ltd,
2012-11-15T18:57:57Z.
|
| Subjects: | |
| Online Access: | Get fulltext |